Low serum levels of GH or IGF1 and IGF1/IGFBP3 ratio (reflecting low IGF1 bioavailability) have been hypothesized to contribute to NAFLD in AOGHD (13, 14). Here, IGF1 is linked to metabolic dysfunction-associated steatotic liver disease.